Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
editorial
. 1995 Nov;71(841):641–642. doi: 10.1136/pgmj.71.841.641

Helicobacter pylori and radical therapy for peptic ulcer.

M C Bateson
PMCID: PMC2398337  PMID: 7494763

Full text

PDF
641

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayerdörffer E., Neubauer A., Rudolph B., Thiede C., Lehn N., Eidt S., Stolte M. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 1995 Jun 24;345(8965):1591–1594. doi: 10.1016/s0140-6736(95)90113-2. [DOI] [PubMed] [Google Scholar]
  2. Bell G. D., Powell K. U., Burridge S. M., Bowden A. F., Atoyebi W., Bolton G. H., Jones P. H., Brown C. Rapid eradication of Helicobacter pylori infection. Aliment Pharmacol Ther. 1995 Feb;9(1):41–46. doi: 10.1111/j.1365-2036.1995.tb00349.x. [DOI] [PubMed] [Google Scholar]
  3. Bernersen B., Johnsen R., Bostad L., Straume B., Sommer A. I., Burhol P. G. Is Helicobacter pylori the cause of dyspepsia? BMJ. 1992 May 16;304(6837):1276–1279. doi: 10.1136/bmj.304.6837.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blecker U., Lanciers S., Hauser B., Vandenplas Y. The prevalence of Helicobacter pylori positivity in a symptom-free population, aged 1 to 40 years. J Clin Epidemiol. 1994 Oct;47(10):1095–1098. doi: 10.1016/0895-4356(94)90095-7. [DOI] [PubMed] [Google Scholar]
  5. Gad A., Hradsky M., Furugård K., Malmodin B., Nyberg O. Campylobacter pylori and non-ulcer dyspepsia. 2. A prospective study in a Swedish population. Scand J Gastroenterol Suppl. 1989;167:44–48. doi: 10.3109/00365528909091310. [DOI] [PubMed] [Google Scholar]
  6. Hosking S. W., Ling T. K., Yung M. Y., Cheng A., Chung S. C., Leung J. W., Li A. K. Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer. BMJ. 1992 Aug 29;305(6852):502–504. doi: 10.1136/bmj.305.6852.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Jaspersen D., Koerner T., Schorr W., Brennenstuhl M., Raschka C., Hammar C. H. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 1995 Jan;41(1):5–7. doi: 10.1016/s0016-5107(95)70267-9. [DOI] [PubMed] [Google Scholar]
  8. Marshall B. J. Helicobacter pylori. Am J Gastroenterol. 1994 Aug;89(8 Suppl):S116–S128. [PubMed] [Google Scholar]
  9. Patchett S., Beattie S., Leen E., Keane C., O'Morain C. Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia. BMJ. 1991 Nov 16;303(6812):1238–1240. doi: 10.1136/bmj.303.6812.1238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Penston J. G. Review article: Helicobacter pylori eradication--understandable caution but no excuse for inertia. Aliment Pharmacol Ther. 1994 Aug;8(4):369–389. doi: 10.1111/j.1365-2036.1994.tb00304.x. [DOI] [PubMed] [Google Scholar]
  11. Phull P. S., Ryder S. D., Halliday D., Price A. B., Levi A. J., Jacyna M. R. The economic and quality-of-life benefits of Helicobacter pylori eradication in chronic duodenal ulcer disease--a community-based study. Postgrad Med J. 1995 Jul;71(837):413–418. doi: 10.1136/pgmj.71.837.413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rokkas T., Karameris A., Mavrogeorgis A., Rallis E., Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995 Jan;41(1):1–4. doi: 10.1016/s0016-5107(95)70266-0. [DOI] [PubMed] [Google Scholar]
  13. Tytgat G. N. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther. 1994 Aug;8(4):359–368. doi: 10.1111/j.1365-2036.1994.tb00303.x. [DOI] [PubMed] [Google Scholar]
  14. Veldhuyzen van Zanten S. J., Pollak P. T., Best L. M., Bezanson G. S., Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis. 1994 Feb;169(2):434–437. doi: 10.1093/infdis/169.2.434. [DOI] [PubMed] [Google Scholar]
  15. Xia H., Keane C. T., Beattie S., O'Morain C. A. Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori. Antimicrob Agents Chemother. 1994 Oct;38(10):2357–2361. doi: 10.1128/aac.38.10.2357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Boer W., Driessen W., Jansz A., Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995 Apr 1;345(8953):817–820. doi: 10.1016/s0140-6736(95)92962-2. [DOI] [PubMed] [Google Scholar]
  17. van Zwet A. A., Thijs J. C., de Graaf B. Explanations for high rates of eradication with triple therapy using metronidazole in patients harboring metronidazole-resistant Helicobacter pylori strains. Antimicrob Agents Chemother. 1995 Jan;39(1):250–252. doi: 10.1128/aac.39.1.250. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES